139 related articles for article (PubMed ID: 19407365)
1. Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.
Li JH; Man YG
Cancer Biomark; 2009; 5(3):109-16. PubMed ID: 19407365
[TBL] [Abstract][Full Text] [Related]
2. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
3. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
[TBL] [Abstract][Full Text] [Related]
4. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
7. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers.
Zhang RR; Man YG; Vang R; Saenger JS; Barner R; Wheeler DT; Liang CY; Vinh TN; Bratthauer GL
Breast Cancer Res; 2003; 5(5):R151-6. PubMed ID: 12927046
[TBL] [Abstract][Full Text] [Related]
8. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation.
Zółtowska A; Moszkowska G; Zamorska B; Roszkiewicz A
Arch Immunol Ther Exp (Warsz); 1996; 44(4):271-7. PubMed ID: 9017169
[TBL] [Abstract][Full Text] [Related]
11. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
[TBL] [Abstract][Full Text] [Related]
12. Lineage infidelity and expression of melanocytic markers in human breast cancer.
Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
[TBL] [Abstract][Full Text] [Related]
14. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
Gupta S; Joshi K; Wig JD; Arora SK
Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
[TBL] [Abstract][Full Text] [Related]
15. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
[TBL] [Abstract][Full Text] [Related]
16. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
[TBL] [Abstract][Full Text] [Related]
17. Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion.
Zhang X; Hashemi SS; Yousefi M; Gao C; Sheng J; Ni J; Wang W; Mason J; Man YG
Pathol Res Pract; 2009; 205(6):375-85. PubMed ID: 19395181
[TBL] [Abstract][Full Text] [Related]
18. Dual use of a single Wilms' tumor 1 immunohistochemistry in evaluation of ovarian tumors: a preliminary study of 20 cases.
Hsiao YH; Siddiqui S; Man YG
J Cancer; 2010 Jul; 1():93-7. PubMed ID: 20842229
[TBL] [Abstract][Full Text] [Related]
19. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
Man YG; Schwartz A; Levine PH; Teal C; Berg PE
Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
